+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Peptide Antibiotics Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • The Business Research Company
  • ID: 5767330
Peptide antibiotics are a type of antibiotics composed of peptides, and their antibacterial activity is based on the physical rupture of cell membranes. These antibiotics are designed to permeate bacterial membranes, accumulate within bacteria, and subsequently interfere with bacterial functioning.

The main types of peptide antibiotics include ribosomally synthesized peptide antibiotics and non-ribosomally synthesized peptide antibiotics. Ribosomally synthesized peptide antibiotics can either destroy or modify the drug, change the drug target, decrease or raise drug uptake, or substitute a different metabolic step as the medication's target. These antibiotics are antimicrobial peptides generated by ribosomes and produced by a wide range of species, from bacteria to plants and animals. Some examples of drugs under the category of peptide antibiotics include daptomycin, dalbavancin, telavancin, and other drugs used to treat various diseases such as skin infections, hospital-acquired bacterial pneumonia (HABP)/ventilator-associated bacterial pneumonia (VABP), bloodstream infections, and other conditions. Peptide antibiotics are utilized and distributed through channels like hospitals, homecare, specialty clinics, and other distribution channels.

The peptide antibiotics market research report is one of a series of new reports that provides peptide antibiotics market statistics, including peptide antibiotics industry global market size, regional shares, competitors with a peptide antibiotics market share, detailed peptide antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the peptide antibiotics industry. This peptide antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptide antibiotics market size has grown rapidly in recent years. It will grow from $4.79 billion in 2023 to $5.31 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historic period can be attributed to factors such as the discovery and development of peptide antibiotics, an increase in antibiotic resistance, a rise in the incidence of infectious diseases, advancements in peptide synthesis technologies, and the overall growth of the pharmaceutical industry.

The peptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period can be attributed to an emphasis on the development of novel antibiotics, the increasing global incidence of antibiotic-resistant infections, the expansion of research and development in antimicrobial peptides, and regulatory support for new antibiotic approvals. Major trends expected in the forecast period include the exploration of natural sources for antimicrobial peptides, the application of peptide antibiotics in animal health, a focus on peptide engineering for enhanced efficacy, the development of combination peptide antibiotics, and the integration of artificial intelligence and machine learning in peptide antibiotic discovery.

The growth of the peptide antibiotics market is anticipated to be propelled by the increasing prevalence of various infectious diseases. These diseases, caused by microorganisms like bacteria, fungi, and parasites, have witnessed a surge due to factors such as rapid urbanization, climate change, and an elevated risk of disease emergence. The demand for peptide antibiotics has risen in response to these trends, as they exert antibacterial activity by physically rupturing cell membranes. Notably, data from the Australian Institute of Health and Welfare revealed a substantial increase in notifiable infectious disease cases in Australia, rising from 2.89 million in 2020 to 7.02 million in 2021. This surge underscores the driving force of the growing incidence of infectious diseases in advancing the peptide antibiotics market.

Another significant driver for the peptide antibiotics market is the escalating incidence of chronic diseases. Chronic conditions, enduring for a year or more and requiring ongoing medical attention, have seen an uptick due to factors such as increased tobacco use, poor nutrition, and sedentary lifestyles. Peptide antibiotics play a crucial role in treating chronic diseases by delivering targeted drug administration. A report by the National Council on Aging, Inc., highlighted that over 85% of the elderly population grapples with at least one chronic illness, contributing to the annual healthcare spending in the US reaching $3.8 trillion. Hence, the rising prevalence of chronic conditions is a key factor propelling the growth of the peptide antibiotics market.

A prominent trend in the peptide antibiotics market is the increasing adoption of strategic partnerships among major companies. This collaborative approach allows companies to expand their market reach and leverage each other's resources effectively. For instance, Berkeley Lights, a US-based digital cell biology company, forged a strategic partnership with Aanika Biosciences in January 2022. Through this collaboration, Aanika Biosciences aims to utilize Berkeley Lights' high-throughput, functional screening service to rapidly identify and refine functional antimicrobial peptides (AMPs) targeting harmful bacteria, particularly those responsible for foodborne disease outbreaks. The partnership also involves the utilization of the Beacon Optofluidic Platform to identify peptides harmful to bacteria, leading to the development of a novel antibacterial tag. This tag will be integrated into Aanika Biosciences' bacterial spore-based barcoding technology to enhance food supply chain security.

Major players in the peptide antibiotics market are also making strategic moves by introducing generic versions, providing a cost-effective alternative for patients. Generic versions, which are off-patent alternatives to brand-name peptide-based antibiotics, offer affordability without compromising efficacy. In July 2023, Camber Pharmaceuticals, a US-based pharmaceutical company, expanded its portfolio by launching a generic version of Daptomycin for Injection. This peptide antibiotic is a cyclic lipopeptide synthesized by nonribosomal machinery and is prescribed for treating complicated skin and skin structure infections (cSSSI) in both adult and pediatric patients aged 1 to 17 years.

Major companies operating in the in the peptide antibiotics market report are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Theravance Biopharma Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, AuroMedics Pharma LLC, EnBiotix Inc., Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, AdvaCare Pharma, Allecra Therapeutics GmbH, AmpliPhi Biosciences Corporation, Antabio, Arsanis Inc., Basilea Pharmaceutica Ltd., BioVersys AG, Curis Inc.

North America was the largest region in the peptide antibiotics market in 2023. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The peptide antibiotics market consists of sales of oral, intravenous, intramuscular and topical peptide antibiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Peptide Antibiotics Market Characteristics3. Peptide Antibiotics Market Trends And Strategies
4. Peptide Antibiotics Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Peptide Antibiotics Market Size and Growth
5.1. Global Peptide Antibiotics Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Peptide Antibiotics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Peptide Antibiotics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Peptide Antibiotics Market Segmentation
6.1. Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Ribosomal Synthesized Peptide Antibiotics
Non-ribosomal Synthesized Peptide Antibiotics
6.2. Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Daptomycin
Dalbavancin
Telavancin
Other Drugs
6.3. Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Skin Infection
HABP/VABP
Blood Stream Infection
Other Diseases
6.4. Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other Distribution Channels
7. Peptide Antibiotics Market Regional And Country Analysis
7.1. Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Peptide Antibiotics Market
8.1. Asia-Pacific Peptide Antibiotics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Peptide Antibiotics Market
9.1. China Peptide Antibiotics Market Overview
9.2. China Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Peptide Antibiotics Market
10.1. India Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Peptide Antibiotics Market
11.1. Japan Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Peptide Antibiotics Market
12.1. Australia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Peptide Antibiotics Market
13.1. Indonesia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Peptide Antibiotics Market
14.1. South Korea Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Peptide Antibiotics Market
15.1. Western Europe Peptide Antibiotics Market Overview
15.2. Western Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Peptide Antibiotics Market
16.1. UK Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Peptide Antibiotics Market
17.1. Germany Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Peptide Antibiotics Market
18.5. France Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Peptide Antibiotics Market
19.9. Italy Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Peptide Antibiotics Market
20.13. Spain Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Peptide Antibiotics Market
21.1. Eastern Europe Peptide Antibiotics Market Overview
21.2. Eastern Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Peptide Antibiotics Market
22.1. Russia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Peptide Antibiotics Market
23.1. North America Peptide Antibiotics Market Overview
23.2. North America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Peptide Antibiotics Market
24.1. USA Peptide Antibiotics Market Overview
24.2. USA Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Peptide Antibiotics Market
25.1. Canada Peptide Antibiotics Market Overview
25.2. Canada Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Peptide Antibiotics Market
26.1. South America Peptide Antibiotics Market Overview
26.2. South America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Peptide Antibiotics Market
27.1. Brazil Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Peptide Antibiotics Market
28.1. Middle East Peptide Antibiotics Market Overview
28.2. Middle East Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Peptide Antibiotics Market
29.1. Africa Peptide Antibiotics Market Overview
29.2. Africa Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Peptide Antibiotics Market Competitive Landscape And Company Profiles
30.1. Peptide Antibiotics Market Competitive Landscape
30.2. Peptide Antibiotics Market Company Profiles
30.2.1. Eli Lilly and Company
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. GlaxoSmithKline plc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Novartis AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Pfizer Inc.
30.2. 4.1. Overview
30.2. 4.2. Products and Services
30.2. 4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Theravance Biopharma Inc
30.2. 5.1. Overview
30.2. 5.2. Products and Services
30.2. 5.3. Strategy
30.2.5.4. Financial Performance
31. Global Peptide Antibiotics Market Competitive Benchmarking32. Global Peptide Antibiotics Market Competitive Dashboard33. Key Mergers And Acquisitions In The Peptide Antibiotics Market
34. Peptide Antibiotics Market Future Outlook and Potential Analysis
34.1 Peptide Antibiotics Market In 2028 - Countries Offering Most New Opportunities
34.2 Peptide Antibiotics Market In 2028 - Segments Offering Most New Opportunities
34.3. Peptide Antibiotics Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Peptide Antibiotics Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptide antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for peptide antibiotics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Type: Ribosomal Synthesized Peptide Antibiotics; Non-ribosomal Synthesized Peptide Antibiotics 2) By Drugs: Daptomycin; Dalbavancin; Telavancin; Other Drugs 3) By Disease Outlook: Skin Infection; HABP/VABP; Blood Stream Infection; Other Diseases 4) By Distribution Channel: Hospitals; Homecare; Specialty Clinics; Other Distribution Channels
  • Companies Mentioned: Eli Lilly and Company; GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; Theravance Biopharma Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Theravance Biopharma Inc.
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Sandoz International GmbH
  • Xellia APS
  • AuroMedics Pharma LLC
  • EnBiotix Inc.
  • Johnson & Johnson Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Lupin Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Wockhardt Ltd.
  • Zydus Lifesciences Limited
  • Alkem Laboratories Limited
  • AdvaCare Pharma
  • Allecra Therapeutics GmbH
  • AmpliPhi Biosciences Corporation
  • Antabio
  • Arsanis Inc.
  • Basilea Pharmaceutica Ltd.
  • BioVersys AG
  • Curis Inc.

Methodology

Loading
LOADING...